These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SECURITIES AND EXCHANGE COMMISSION
|
|
|
Washington, D.C. 20549
|
|
|
FORM 10-Q
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
|
|
|
THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended
March 31, 2011
|
|
|
Commission file number
1-640
|
|
|
NL INDUSTRIES, INC.
|
|
|
(Exact name of registrant as specified in its charter)
|
|
|
New Jersey
|
13-5267260
|
|
(State or other jurisdiction of
incorporation or organization)
|
(IRS Employer Identification No.)
|
|
|
|
|
|
|
|
5430 LBJ Freeway, Suite 1700
|
|
|
Dallas, Texas 75240-2697
|
|
|
(Address of principal executive offices)
|
|
|
|
|
|
Registrant's telephone number, including area code:
(972) 233-1700
|
|
|
*
|
The registrant has not yet been phased into the interactive data requirements
|
|
Page
|
||
|
number
|
||
|
|
FINANCIAL INFORMATION
|
|
|
Item 1.
|
Financial Statements
|
|
|
Condensed Consolidated Balance Sheets -
|
||
|
December 31, 2010; March 31, 2011 (unaudited)
|
3
|
|
|
Condensed Consolidated Statements of Operations (unaudited)-
|
||
|
Three months ended March 31, 2010 and 2011
|
5
|
|
|
Condensed Consolidated Statement of Stockholders' Equity
|
||
|
and Comprehensive Income -
|
||
|
Three months ended March 31, 2011 (unaudited)
|
6
|
|
|
Condensed Consolidated Statements of Cash Flows (unaudited) -
|
||
|
Three months ended March 31, 2010 and 2011
|
7
|
|
|
Notes to Condensed Consolidated Financial Statements
|
||
|
(unaudited)
|
9
|
|
|
Item 2.
|
Management's Discussion and Analysis of Financial
|
|
|
Condition and Results of Operations
|
22
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosure About Market Risk
|
39
|
|
Item 4.
|
Controls and Procedures
|
39
|
|
|
OTHER INFORMATION
|
|
|
Item 1.
|
Legal Proceedings
|
41
|
|
Item 1A.
|
Risk Factors
|
41
|
|
Item 6.
|
Exhibits
|
41
|
|
Items 2, 3, 4 and 5 of Part II are omitted because there is no information to report
|
||
|
ASSETS
|
December 31,
2010
|
March 31,
2011
|
||||||
|
(unaudited)
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$ | 15,461 | $ | 9,694 | ||||
|
Restricted cash and cash equivalents
|
7,413 | 5,416 | ||||||
|
Marketable securities
|
9 | - | ||||||
|
Accounts and other receivables, net
|
31,663 | 31,736 | ||||||
|
Inventories, net
|
18,424 | 19,434 | ||||||
|
Prepaid expenses and other
|
1,285 | 2,656 | ||||||
|
Deferred income taxes
|
7,724 | 7,724 | ||||||
|
Total current assets
|
81,979 | 76,660 | ||||||
|
Other assets:
|
||||||||
|
Marketable equity securities
|
130,824 | 153,263 | ||||||
|
Investment in Kronos Worldwide, Inc.
|
231,693 | 233,537 | ||||||
|
Goodwill
|
44,819 | 44,801 | ||||||
|
Assets held for sale
|
2,415 | 2,415 | ||||||
|
Other, net
|
1,447 | 1,339 | ||||||
|
Total other assets
|
411,198 | 435,355 | ||||||
|
Property and equipment:
|
||||||||
|
Land
|
12,963 | 12,957 | ||||||
|
Buildings
|
34,981 | 35,470 | ||||||
|
Equipment
|
129,260 | 130,792 | ||||||
|
Construction in progress
|
965 | 1,456 | ||||||
| 178,169 | 180,675 | |||||||
|
Less accumulated depreciation
|
117,621 | 120,817 | ||||||
|
Net property and equipment
|
60,548 | 59,858 | ||||||
|
Total assets
|
$ | 553,725 | $ | 571,873 | ||||
|
LIABILITIES AND EQUITY
|
December 31,
2010
|
March 31,
2011
|
||||||
|
(unaudited)
|
||||||||
|
Current liabilities:
|
||||||||
|
Current maturities of long-term debt
|
$ | 10,000 | $ | 10,000 | ||||
|
Accounts payable
|
9,179 | 6,142 | ||||||
|
Accrued and other current liabilities
|
16,940 | 11,974 | ||||||
|
Accrued environmental costs
|
8,206 | 8,407 | ||||||
|
Income taxes
|
909 | 1,754 | ||||||
|
Total current liabilities
|
45,234 | 38,277 | ||||||
|
Non-current liabilities:
|
||||||||
|
Long-term debt
|
64,530 | 45,980 | ||||||
|
Accrued pension costs
|
8,550 | 8,126 | ||||||
|
Accrued postretirement benefit (OPEB) costs
|
5,459 | 5,384 | ||||||
|
Accrued environmental costs
|
32,194 | 31,405 | ||||||
|
Deferred income taxes
|
115,206 | 130,123 | ||||||
|
Other
|
18,697 | 18,596 | ||||||
|
Total non-current liabilities
|
244,636 | 239,614 | ||||||
|
Equity:
|
||||||||
|
NL Stockholders' equity:
|
||||||||
|
Common stock
|
6,078 | 6,082 | ||||||
|
Additional paid-in capital
|
299,469 | 299,807 | ||||||
|
Retained earnings
|
56,229 | 67,314 | ||||||
|
Accumulated other comprehensive loss
|
(108,827 | ) | (90,484 | ) | ||||
|
Total NL stockholders' equity
|
252,949 | 282,719 | ||||||
|
Noncontrolling interest in subsidiary
|
10,906 | 11,263 | ||||||
|
Total equity
|
263,855 | 293,982 | ||||||
|
Total liabilities and equity
|
$ | 553,725 | $ | 571,873 | ||||
|
Three months ended
March 31,
|
|||||||||
|
2010
|
2011
|
||||||||
|
(unaudited)
|
|||||||||
|
Net sales
|
$ | 32,800 | $ | 34,777 | |||||
|
Cost of sales
|
23,701 | 26,097 | |||||||
|
Gross margin
|
9,099 | 8,680 | |||||||
|
Selling, general and administrative expense
|
5,795 | 6,156 | |||||||
|
Other operating income (expense):
|
|||||||||
|
Insurance recoveries
|
18,175 | 359 | |||||||
|
Litigation settlement expense
|
(32,174 | ) | - | ||||||
|
Patent litigation settlement gain
|
- | 7,468 | |||||||
|
Patent litigation expense
|
(1,568 | ) | (227 | ) | |||||
|
Facility consolidation expense
|
- | (1,006 | ) | ||||||
|
Corporate expense and other, net
|
(4,619 | ) | (3,400 | ) | |||||
|
Income (loss) from operations
|
(16,882 | ) | 5,718 | ||||||
|
Equity in net income of Kronos Worldwide, Inc.
|
15,396 | 18,329 | |||||||
|
Other income (expense):
|
|||||||||
|
Interest and dividends
|
606 | 596 | |||||||
|
Interest expense
|
(197 | ) | (489 | ) | |||||
|
Income (loss) before income taxes
|
(1,077 | ) | 24,154 | ||||||
|
Provision for income taxes
|
1,343 | 6,469 | |||||||
|
Net income (loss)
|
(2,420 | ) | 17,685 | ||||||
|
Noncontrolling interest in net income (loss) of subsidiary
|
(125 | ) | 518 | ||||||
|
Net income (loss) attributable to NL stockholders
|
$ | (2,295 | ) | $ | 17,167 | ||||
|
Amounts attributable to NL stockholders:
|
|||||||||
|
Basic and diluted net income (loss) per share
|
$ | (.10 | ) | $ | .35 | ||||
|
Cash dividend per share
|
$ | .125 | $ | .125 | |||||
|
Basic and diluted average shares outstanding
|
48,618 | 48,648 | |||||||
|
NL Stockholders’ Equity
|
||||||||||||||||||||||||||||
|
Common
stock
|
Additional
paid-in
capital
|
Retained
earnings
|
Accumulated
other
comprehensive
loss
|
Noncontrolling
interest in
subsidiary
|
Total
equity
|
Comprehensive
income
|
||||||||||||||||||||||
|
(unaudited)
|
||||||||||||||||||||||||||||
|
Balance at December 31, 2010
|
$ | 6,078 | $ | 299,469 | $ | 56,229 | $ | (108,827 | ) | $ | 10,906 | $ | 263,855 | |||||||||||||||
|
Net income
|
- | - | 17,167 | - | 518 | 17,685 | $ | 17,685 | ||||||||||||||||||||
|
Other comprehensive income, net
|
- | - | - | 18,343 | 42 | 18,385 | 18,385 | |||||||||||||||||||||
|
Issuance of common stock
|
4 | 338 | - | - | - | 342 | ||||||||||||||||||||||
|
Dividends
|
- | - | (6,082 | ) | - | (203 | ) | (6,285 | ) | |||||||||||||||||||
|
Balance at March 31, 2011
|
$ | 6,082 | $ | 299,807 | $ | 67,314 | $ | (90,484 | ) | $ | 11,263 | $ | 293,982 | |||||||||||||||
|
Comprehensive income
|
$ | 36,070 | ||||||||||||||||||||||||||
|
Three months ended
March 31,
|
||||||||
|
2010
|
2011
|
|||||||
|
(unaudited)
|
||||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income (loss)
|
$ | (2,420 | ) | $ | 17,685 | |||
|
Depreciation and amortization
|
1,979 | 1,760 | ||||||
|
Deferred income taxes
|
2,158 | 4,837 | ||||||
|
Equity in net income of Kronos Worldwide, Inc.
|
(15,396 | ) | (18,329 | ) | ||||
|
Distributions from Kronos Worldwide, Inc.
|
- | 22,012 | ||||||
|
Accrued litigation settlement
|
32,174 | - | ||||||
|
Benefit plan expense greater (less) than cash funding:
|
||||||||
|
Defined benefit pension expense
|
187 | (71 | ) | |||||
|
Other postretirement benefit expense
|
64 | (141 | ) | |||||
|
Other, net
|
168 | 150 | ||||||
|
Change in assets and liabilities:
|
||||||||
|
Accounts and other receivables, net
|
(21,701 | ) | (1,411 | ) | ||||
|
Inventories, net
|
(1,134 | ) | (992 | ) | ||||
|
Prepaid expenses and other
|
(853 | ) | (1,214 | ) | ||||
|
Accrued environmental costs
|
(1,195 | ) | (588 | ) | ||||
|
Accounts payable and accrued liabilities
|
(847 | ) | (8,034 | ) | ||||
|
Income taxes
|
(342 | ) | 834 | |||||
|
Accounts with affiliates
|
2,555 | 1,245 | ||||||
|
Other, net
|
(437 | ) | (393 | ) | ||||
|
Net cash provided by (used in) operating activities
|
(5,040 | ) | 17,350 | |||||
|
Cash flows from investing activities:
|
||||||||
|
Capital expenditures
|
(446 | ) | (605 | ) | ||||
|
Change in restricted cash equivalents
|
3,780 | 1,997 | ||||||
|
Proceeds from disposal of marketable securities
|
1,263 | 116 | ||||||
|
Purchase of marketable securities
|
- | (104 | ) | |||||
|
Net cash provided by investing activities
|
4,597 | 1,404 | ||||||
|
Three months ended
March 31,
|
||||||||
|
2010
|
2011
|
|||||||
|
(unaudited)
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Cash dividends paid
|
$ | (6,077 | ) | $ | (6,082 | ) | ||
|
Distributions to noncontrolling interests in subsidiary
|
(202 | ) | (203 | ) | ||||
|
Proceeds from issuance of common stock
|
69 | 342 | ||||||
|
Indebtedness:
|
||||||||
|
Borrowings
|
- | 3,600 | ||||||
|
Repayments
|
- | (22,150 | ) | |||||
|
Other, net
|
(29 | ) | - | |||||
|
Net cash used in financing activities
|
(6,239 | ) | (24,493 | ) | ||||
|
Cash and cash equivalents - net change from:
|
||||||||
|
Operating, investing and financing activities
|
(6,682 | ) | (5,739 | ) | ||||
|
Currency translation
|
107 | (28 | ) | |||||
|
Cash and cash equivalents at beginning of period
|
24,555 | 15,461 | ||||||
|
Cash and cash equivalents at end of period
|
$ | 17,980 | $ | 9,694 | ||||
|
Supplemental disclosures:
|
||||||||
|
Cash paid (received) for:
|
||||||||
|
Interest
|
$ | 47 | $ | 1,349 | ||||
|
Income taxes, net
|
(2,509 | ) | (521 | ) | ||||
|
Non-cash investing activity:
|
||||||||
|
Accrual for capital expenditures
|
112 | 133 | ||||||
|
Non-cash financing activity:
|
||||||||
|
Promissory note payable incurred in connection
with litigation settlement
|
18,000 | - | ||||||
|
December 31,
2010
|
March 31,
2011
|
|||||||
|
(In thousands)
|
||||||||
|
Trade receivables
|
$ | 15,068 | $ | 16,270 | ||||
|
Promissory note receivable
|
15,000 | 15,000 | ||||||
|
Accrued insurance recoveries
|
92 | 423 | ||||||
|
Other receivables
|
59 | 49 | ||||||
|
Receivable from affiliates:
|
||||||||
|
Income taxes from Valhi
|
1,700 | 377 | ||||||
|
Other
|
129 | - | ||||||
|
Refundable income taxes
|
4 | - | ||||||
|
Allowance for doubtful accounts
|
(389 | ) | (383 | ) | ||||
|
Total
|
$ | 31,663 | $ | 31,736 | ||||
|
December 31,
2010
|
March 31,
2011
|
|||||||
|
(In thousands)
|
||||||||
|
Raw materials
|
$ | 6,393 | $ | 6,661 | ||||
|
Work in process
|
6,680 | 7,565 | ||||||
|
Finished products
|
5,351 | 5,208 | ||||||
|
Total
|
$ | 18,424 | $ | 19,434 | ||||
|
December 31,
2010
|
March 31,
2011
|
|||||||
|
(In thousands)
|
||||||||
|
Current assets (available-for-sale)-
|
||||||||
|
Other marketable securities
|
$ | 9 | $ | - | ||||
|
Noncurrent assets (available-for-sale):
|
||||||||
|
Valhi common stock
|
$ | 105,929 | $ | 126,339 | ||||
|
TIMET common stock
|
24,895 | 26,924 | ||||||
|
Total
|
$ | 130,824 | $ | 153,263 | ||||
|
Market
value
|
Cost
basis
|
Unrealized
gains
|
||||||||||
|
(In thousands)
|
||||||||||||
|
December 31, 2010:
|
||||||||||||
|
Noncurrent assets:
|
||||||||||||
|
Valhi common stock
|
$ | 105,929 | $ | 24,347 | $ | 81,582 | ||||||
|
TIMET common stock
|
24,895 | 7,351 | 17,544 | |||||||||
|
Total
|
$ | 130,824 | $ | 31,698 | $ | 99,126 | ||||||
|
|
||||||||||||
|
March 31, 2011:
|
||||||||||||
|
Noncurrent assets:
|
||||||||||||
|
Valhi common stock
|
$ | 126,339 | $ | 24,347 | $ | 101,992 | ||||||
|
TIMET common stock
|
26,924 | 7,351 | 19,573 | |||||||||
|
Total
|
$ | 153,263 | $ | 31,698 | $ | 121,565 | ||||||
|
Amount
|
||||
|
(In millions)
|
||||
|
Balance at the beginning of the period
|
$ | 231.7 | ||
|
Equity in net income of Kronos
|
18.3 | |||
|
Dividends received from Kronos
|
(22.0 | ) | ||
|
Other, principally equity in other comprehensive income
items of Kronos
|
5.5 | |||
|
Balance at the end of the period
|
$ | 233.5 | ||
|
December 31,
2010
|
March 31,
2011
|
|||||||
|
(In millions)
|
||||||||
|
Current assets
|
$ | 824.3 | $ | 915.9 | ||||
|
Property and equipment, net
|
473.6 | 490.6 | ||||||
|
Investment in TiO
2
joint venture
|
96.2 | 95.1 | ||||||
|
Other noncurrent assets
|
313.5 | 280.6 | ||||||
|
Total assets
|
$ | 1,707.6 | $ | 1,782.2 | ||||
|
Current liabilities
|
$ | 220.1 | $ | 250.6 | ||||
|
Long-term debt
|
537.4 | 567.6 | ||||||
|
Accrued pension and postretirement benefits
|
130.1 | 132.8 | ||||||
|
Other non-current liabilities
|
58.8 | 63.9 | ||||||
|
Stockholders’ equity
|
761.2 | 767.3 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 1,707.6 | $ | 1,782.2 | ||||
|
Three months ended
March 31,
|
||||||||
|
2010
|
2011
|
|||||||
|
(In millions)
|
||||||||
|
Net sales
|
$ | 319.7 | $ | 420.4 | ||||
|
Cost of sales
|
259.2 | 274.0 | ||||||
|
Income from operations
|
21.7 | 102.4 | ||||||
|
Net income
|
42.8 | 60.3 | ||||||
|
December 31,
2010
|
March 31,
2011
|
|||||||
|
(In thousands)
|
||||||||
|
Patents and other intangible assets, net
|
$ | 840 | $ | 701 | ||||
|
Other
|
607 | 638 | ||||||
|
Total
|
$ | 1,447 | $ | 1,339 | ||||
|
December 31,
2010
|
March 31,
2011
|
|||||||
|
(In thousands)
|
||||||||
|
Employee benefits
|
$ | 9,624 | $ | 6,345 | ||||
|
Professional fees and legal settlements
|
3,077 | 2,629 | ||||||
|
Payable to affiliates:
|
||||||||
|
Accrued interest payable to TIMET
|
876 | 4 | ||||||
|
Other
|
541 | 335 | ||||||
|
Other
|
2,822 | 2,661 | ||||||
|
Total
|
$ | 16,940 | $ | 11,974 | ||||
|
December 31,
2010
|
March 31,
2011
|
|||||||
|
(In thousands)
|
||||||||
|
NL:
|
||||||||
|
Promissory note payable to Valhi
|
$ | 11,300 | $ | - | ||||
|
Promissory note issued in conjunction with litigation settlement
|
18,000 | 18,000 | ||||||
|
Subtotal
|
29,300 | 18,000 | ||||||
|
Subsidiary debt:
|
||||||||
|
CompX credit facility
|
3,000 | - | ||||||
|
CompX promissory note payable to TIMET
|
42,230 | 37,980 | ||||||
|
Subtotal
|
45,230 | 37,980 | ||||||
|
Total debt
|
74,530 | 55,980 | ||||||
|
Less current maturities
|
10,000 | 10,000 | ||||||
|
Total long-term debt
|
$ | 64,530 | $ | 45,980 | ||||
|
December 31,
2010
|
March 31,
2011
|
|||||||
|
(In thousands)
|
||||||||
|
Reserve for uncertain tax positions
|
$ | 16,832 | $ | 16,832 | ||||
|
Insurance claims and expenses
|
688 | 679 | ||||||
|
Other
|
1,177 | 1,085 | ||||||
|
Total
|
$ | 18,697 | $ | 18,596 | ||||
|
Three months ended
March 31,
|
||||||||
|
2010
|
2011
|
|||||||
|
(In thousands)
|
||||||||
|
Interest cost
|
$ | 720 | $ | 687 | ||||
|
Expected return on plan assets
|
(846 | ) | (975 | ) | ||||
|
Recognized actuarial losses
|
313 | 217 | ||||||
|
Total
|
$ | 187 | $ | (71 | ) | |||
|
Three months ended
March 31,
|
||||||||
|
2010
|
2011
|
|||||||
|
(In thousands)
|
||||||||
|
Interest cost
|
$ | 109 | $ | 59 | ||||
|
Amortization of prior service credit
|
(45 | ) | (200 | ) | ||||
|
Total
|
$ | 64 | $ | (141 | ) | |||
|
Three months ended
March 31,
|
||||||||
|
2010
|
2011
|
|||||||
|
(In millions)
|
||||||||
|
Expected tax provision (benefit) at U.S. federal statutory income tax rate of 35%
|
$ | (.4 | ) | $ | 8.5 | |||
|
Non-U.S. tax rates
|
(.1 | ) | (.7 | ) | ||||
|
Incremental U.S. tax and rate differences on equity
in earnings
|
1.8 | (1.3 | ) | |||||
|
Total
|
$ | 1.3 | $ | 6.5 | ||||
|
·
|
we have never settled any of the market share, risk contribution, intentional tort, fraud, nuisance, supplier negligence, breach of warranty, conspiracy, misrepresentation, aiding and abetting, enterprise liability, or statutory cases,
|
|
·
|
no final, non-appealable adverse verdicts have ever been entered against us, and
|
|
·
|
we have never ultimately been found liable with respect to any such litigation matters.
|
|
·
|
complexity and differing interpretations of governmental regulations,
|
|
·
|
number of PRPs and their ability or willingness to fund such allocation of costs,
|
|
·
|
financial capabilities of the PRPs and the allocation of costs among them,
|
|
·
|
solvency of other PRPs,
|
|
·
|
multiplicity of possible solutions,
|
|
·
|
number of years of investigatory, remedial and monitoring activity required and
|
|
·
|
number of years between former operations and notice of claims and lack of information and documents about the former operations.
|
|
Amount
|
||||
|
(In thousands)
|
||||
|
Balance at the beginning of the period
|
$ | 40,400 | ||
|
Additions charged to expense, net
|
162 | |||
|
Payments, net
|
(750 | ) | ||
|
Balance at the end of the period
|
$ | 39,812 | ||
|
Amounts recognized in the balance sheet at the end of the period:
|
||||
|
Current liability
|
$ | 8,407 | ||
|
Noncurrent liability
|
31,405 | |||
|
Total
|
$ | 39,812 | ||
|
·
|
facts concerning historical operations,
|
|
·
|
the rate of new claims,
|
|
·
|
the number of claims from which we have been dismissed and
|
|
·
|
our prior experience in the defense of these matters,
|
|
December 31, 2010
|
March 31, 2011
|
|||||||||||||||
|
Carrying
Amount
|
Fair
Value
|
Carrying
Amount
|
Fair
Value
|
|||||||||||||
|
(in millions)
|
||||||||||||||||
|
Cash and cash equivalents, current restricted cash equivalents and current marketable securities
|
$ | 22.9 | $ | 22.9 | $ | 15.1 | $ | 15.1 | ||||||||
|
Promissory note receivable
|
15.0 | 15.0 | 15.0 | 15.0 | ||||||||||||
|
Notes payable to affiliates
|
53.5 | 53.5 | 38.0 | 38.0 | ||||||||||||
|
CompX bank credit facility
|
3.0 | 3.0 | - | - | ||||||||||||
|
Promissory note payable
|
18.0 | 18.0 | 18.0 | 18.0 | ||||||||||||
|
Noncontrolling interest in CompX common stock
|
10.9 | 18.6 | 11.3 | 25.5 | ||||||||||||
|
NL stockholders’ equity
|
252.9 | 542.7 | 282.7 | 722.6 | ||||||||||||
|
Three months ended
March 31,
|
||||||||
|
2010
|
2011
|
|||||||
|
(In thousands)
|
||||||||
|
Net income (loss) attributable to NL stockholders
|
$ | (2,295 | ) | $ | 17,167 | |||
|
Paid-in capital adjustment
|
(2,513 | ) | - | |||||
|
Adjusted net income (loss) attributable to NL stockholders
|
$ | (4,808 | ) | $ | 17,167 | |||
|
·
|
Future supply and demand for our products,
|
|
·
|
The extent of the dependence of certain of our businesses on certain market sectors,
|
|
·
|
The cyclicality of our businesses (such as Kronos’ TiO
2
operations),
|
|
·
|
Changes in raw material and other operating costs (such as energy, ore and steel costs)and our ability to pass those costs on to our customers or offset them with reductions in other operating costs,
|
|
·
|
Changes in the availability of raw material (such as ore),
|
|
·
|
General global economic and political conditions (such as changes in the level of gross domestic product in various regions of the world and the impact of such changes on demand for, among other things, TiO
2
and component products),
|
|
·
|
Possible disruption of our business or increases in the cost of doing business resulting from terrorist activities or global conflicts,
|
|
·
|
Competitive products and prices, including increased competition from low-cost manufacturing sources (such as China),
|
|
·
|
Customer and competitor strategies,
|
|
·
|
Potential consolidation of Kronos’ competitors,
|
|
·
|
Demand for office furniture,
|
|
·
|
Substitute products,
|
|
·
|
The impact of pricing and production decisions,
|
|
·
|
Competitive technology positions,
|
|
·
|
Our ability to protect our intellectual property rights in our technology,
|
|
·
|
The introduction of trade barriers,
|
|
·
|
Service industry employment levels,
|
|
·
|
Fluctuations in currency exchange rates (such as changes in the exchange rate between the U.S. dollar and each of the euro, the Norwegian krone, the Canadian dollar and the New Taiwan dollar),
|
|
·
|
Operating interruptions (including, but not limited to, labor disputes, leaks, natural disasters, fires, explosions, unscheduled or unplanned downtime and transportation interruptions),
|
|
·
|
The timing and amounts of insurance recoveries,
|
|
·
|
Our ability to maintain sufficient liquidity,
|
|
·
|
The extent to which our subsidiaries were to become unable to pay us dividends,
|
|
·
|
CompX’s and Kronos’ ability to renew or refinance debt,
|
|
·
|
CompX’s ability to comply with covenants contained in its revolving bank credit facility,
|
|
·
|
The ultimate outcome of income tax audits, tax settlement initiatives or other tax matters,
|
|
·
|
Potential difficulties in integrating completed or future acquisitions,
|
|
·
|
Decisions to sell operating assets other than in the ordinary course of business,
|
|
·
|
Uncertainties associated with the development of new product features,
|
|
·
|
Our ability to utilize income tax attributes or changes in income tax rates related to such attributes, the benefits of which have been recognized under the more-likely-than-not recognition criteria,
|
|
·
|
Environmental matters (such as those requiring compliance with emission and discharge standards for existing and new facilities or new developments regarding environmental remediation at sites related to our former operations),
|
|
·
|
Government laws and regulations and possible changes therein (such as changes in government regulations which might impose various obligations on present and former manufacturers of lead pigment and lead-based paint, including us, with respect to asserted health concerns associated with the use of such products),
|
|
·
|
The ultimate resolution of pending litigation (such as our lead pigment and environmental matters) and
|
|
·
|
Possible future litigation.
|
|
·
|
higher equity in net income from Kronos in 2011 due to Kronos’ higher income from operations in 2011 partially offset by an income tax benefit recognized by Kronos in 2010 as well as a reduction of our ownership interest from 36% in the first quarter of 2010 to 30% in 2011 as a result of Kronos’ secondary stock offering completed in November 2010,
|
|
·
|
higher income from operations from component products in 2011 due principally to a patent litigation settlement gain as discussed below,
|
|
·
|
a litigation settlement expense in 2010 as discussed below and
|
|
·
|
higher insurance recoveries in 2010 primarily related to the litigation settlement.
|
|
·
|
income of $.06 per share, net of noncontrolling interest and income taxes, related to a CompX patent litigation settlement and
|
|
·
|
a charge of $.01 per share included in our equity in Kronos in 2011 consisting of a call premium and the write-off of unamortized deferred financing costs and original issue discount associated with Kronos’ redemption of Senior Notes.
|
|
·
|
income included in our equity in earnings of Kronos of $.17 per share related to an income tax benefit recognized by Kronos related to a European Court ruling that resulted in the favorable resolution of certain German income tax issues,
|
|
·
|
income of $.24 per share related to certain insurance recoveries we recognized,
|
|
·
|
a charge of $.43 per share related to a litigation settlement, and
|
|
·
|
a charge of $.03 per share, net of noncontrolling interest, related to recognition of a deferred income tax liability associated with a determination that certain undistributed earnings of CompX’s Taiwanese subsidiary could no longer be considered permanently reinvested.
|
|
Three months ended
|
||||||||||||
|
March 31,
|
%
|
|||||||||||
|
2010
|
2011
|
Change
|
||||||||||
|
(In millions)
|
||||||||||||
|
CompX
|
$ | 1.7 | $ | 8.8 | 405 | % | ||||||
|
Insurance recoveries
|
18.2 | .4 | (98 | )% | ||||||||
|
Litigation settlement
|
(32.2 | ) | - | (100 | )% | |||||||
|
Corporate expense and other, net
|
(4.6 | ) | (3.5 | ) | (24 | )% | ||||||
|
Income (loss) from operations
|
$ | (16.9 | ) | $ | 5.7 | 134 | % | |||||
|
Three months ended
|
||||||||||||
|
March 31,
|
%
|
|||||||||||
|
2010
|
2011
|
Change
|
||||||||||
|
(In millions)
|
||||||||||||
|
Net sales
|
$ | 32.8 | $ | 34.8 | 6 | % | ||||||
|
Cost of sales
|
23.7 | 26.1 | 10 | % | ||||||||
|
Gross margin
|
9.1 | 8.7 | 4 | % | ||||||||
|
Operating costs and expenses
|
(5.8 | ) | (6.2 | ) | 7 | % | ||||||
|
Patent litigation settlement gain
|
- | 7.5 | 100 | % | ||||||||
|
Patent litigation expense
|
(1.6 | ) | (.2 | ) | (86 | )% | ||||||
|
Facility consolidation expense
|
- | (1.0 | ) | 100 | % | |||||||
|
Income from operations
|
$ | 1.7 | $ | 8.8 | 405 | % | ||||||
|
Percentage of net sales:
|
||||||||||||
|
Cost of sales
|
72 | % | 75 | % | ||||||||
|
Income from operations
|
5 | % | 26 | % | ||||||||
|
Impact of changes in currency exchange rates
Three months ended March 31, 2011 vs March 31, 2010
|
||||||||||||||||||||
|
Transaction gains/(losses)
recognized
|
Translation gain/loss-
impact of
rate changes
|
Total
currency impact
2011 vs 2010
|
||||||||||||||||||
|
2010
|
2011
|
Change
|
||||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||
|
Impact on:
|
||||||||||||||||||||
|
Net sales
|
$ | - | $ | - | $ | - | $ | 172 | $ | 172 | ||||||||||
|
Income from operations
|
(55 | ) | (46 | ) | 9 | (393 | ) | (384 | ) | |||||||||||
|
Three months ended
March 31,
|
%
|
|||||||||||
|
2010
|
2011
|
Change
|
||||||||||
|
(In thousands)
|
||||||||||||
|
Net sales:
|
||||||||||||
|
Security Products
|
$ | 16,662 | $ | 17,788 | 7 | % | ||||||
|
Furniture Components
|
14,116 | 14,895 | 6 | % | ||||||||
|
Marine Components
|
2,022 | 2,094 | 4 | % | ||||||||
|
Total net sales
|
$ | 32,800 | $ | 34,777 | 6 | % | ||||||
|
Gross margin:
|
||||||||||||
|
Security Products
|
$ | 5,527 | $ | 5,844 | 6 | % | ||||||
|
Furniture Components
|
3,348 | 2,588 | (23 | )% | ||||||||
|
Marine Components
|
224 | 248 | 11 | % | ||||||||
|
Total gross margin
|
$ | 9,099 | $ | 8,680 | (5 | )% | ||||||
|
Income (loss) from operations:
|
||||||||||||
|
Security Products
|
$ | 3,383 | $ | 3,574 | 6 | % | ||||||
|
Furniture Components
|
7 | 6,874 |
n.m.
|
|||||||||
|
Marine Components
|
(369 | ) | (355 | ) | 4 | % | ||||||
|
Corporate operating expenses
|
(1,284 | ) | (1,333 | ) | (4 | )% | ||||||
|
Total income from operations
|
$ | 1,737 | $ | 8,760 | 405 | % | ||||||
|
·
|
litigation and related costs of $1.8 million in 2011 compared to $2.9 million in 2010 and
|
|
·
|
environmental expenses of $162,000 in 2011, compared to $98,000 in 2010.
|
|
Three months ended
|
||||||||||||
|
March 31,
|
%
|
|||||||||||
|
2010
|
2011
|
Change
|
||||||||||
|
(In millions)
|
||||||||||||
|
Kronos historical:
|
||||||||||||
|
Net sales
|
$ | 319.7 | $ | 420.4 | 31 | % | ||||||
|
Cost of sales
|
259.2 | 274.0 | 6 | % | ||||||||
|
Gross margin
|
$ | 60.5 | $ | 146.4 | ||||||||
|
Income from operations
|
$ | 21.7 | $ | 102.4 | 372 | % | ||||||
|
Interest and dividend income
|
- | 1.7 | 100 | % | ||||||||
|
Loss on prepayment of debt
|
- | (3.3 | ) | 100 | % | |||||||
|
Interest expense
|
(10.4 | ) | (9.6 | ) | (8 | )% | ||||||
| 11.3 | 91.2 | |||||||||||
|
Income tax expense (benefit)
|
(31.5 | ) | 30.9 | 198 | % | |||||||
|
Net income
|
$ | 42.8 | $ | 60.3 | ||||||||
|
Equity in net income of Kronos Worldwide, Inc.
|
$ | 15.4 | $ | 18.3 | ||||||||
|
Percentage of net sales:
|
||||||||||||
|
Cost of sales
|
81 | % | 65 | % | ||||||||
|
Income from operations
|
7 | % | 24 | % | ||||||||
|
TiO
2
operating statistics:
|
||||||||||||
|
Sales volumes*
|
122 | 125 | 2 | % | ||||||||
|
Production volumes*
|
124 | 133 | 7 | % | ||||||||
|
Change in TiO
2
net sales:
|
||||||||||||
|
Ti0
2
product pricing
|
32 | % | ||||||||||
|
Ti0
2
sales volume
|
2 | |||||||||||
|
Ti0
2
product mix
|
(2 | ) | ||||||||||
|
Changes in currency exchange rates
|
(1 | ) | ||||||||||
|
Total
|
31 | % | ||||||||||
|
Impact of changes in currency exchange rates
Three months ended March 31, 2011 vs March 31, 2010
|
||||||||||||||||||||
|
Transaction gains recognized
|
Translation gain/loss-
impact of
rate changes
|
Total currency impact
2011 vs 2010
|
||||||||||||||||||
|
2010
|
2011
|
Change
|
||||||||||||||||||
|
(in millions)
|
||||||||||||||||||||
|
Impact on:
|
||||||||||||||||||||
|
Net sales
|
$ | - | $ | - | $ | - | $ | (5 | ) | $ | (5 | ) | ||||||||
|
Income (loss)
from operations
|
3 | 1 | (2 | ) | (7 | ) | (9 | ) | ||||||||||||
|
·
|
Aggregate dividends from Kronos of $22.0 million in the first quarter of 2011 (including $17.6 million attributable to Kronos’ special dividend of $1.00 per share) compared to nil in the first quarter of 2010,
|
|
·
|
Improved results from operations in 2011 of $7.9 million (including the impact of CompX’s patent litigation settlement gain in the first quarter of 2011, and excluding the impact of each of the litigation settlements and insurance recoveries accrued in the first quarter of 2010),
|
|
·
|
Higher net use of cash from relative changes in receivables, inventories, payables and accrued liabilities in 2011 of $4.3 million (excluding liability related to a litigation settlement, net of insurance recovery in 2010),
|
|
·
|
Lower cash refunded from income taxes in 2011 of $2.0 million and
|
|
·
|
Higher cash paid for interest in 2011 of $1.3 million due mainly to timing of interest payments as discussed in Note 8 to our Condensed Consolidated Financial Statements.
|
|
Three months ended
March 31,
|
||||||||
|
2010
|
2011
|
|||||||
|
(In millions)
|
||||||||
|
Cash provided by (used in) operating activities:
|
||||||||
|
CompX
|
$ | (2.5 | ) | $ | .1 | |||
|
NL Parent and wholly-owned subsidiaries
|
(1.2 | ) | 18.6 | |||||
|
Eliminations
|
(1.3 | ) | (1.3 | ) | ||||
|
Total
|
$ | (5.0 | ) | $ | 17.4 | |||
|
|
December 31,
2009
|
March 31,
2010
|
December 31,
2010
|
March 31,
2011
|
|
Days sales outstanding
|
37 days
|
43 days
|
41 days
|
41 days
|
|
Days in inventory
|
64 days
|
67 days
|
70 days
|
68 days
|
|
·
|
we had $605,000 in capital expenditures, substantially all of which related to CompX,
|
|
·
|
we reduced restricted cash by $3.8 million due to the release of funds to us from escrow related to a litigation settlement,
|
|
·
|
we redeemed $1.3 million of restricted marketable securities in a payout related to the reduction of one of our letters of credit, and
|
|
·
|
we had $446,000 in capital expenditures, substantially all of which related to CompX.
|
|
·
|
we paid a net $11.3 million on a promissory note with Valhi and
|
|
·
|
CompX paid $7.3 million in principal repayments on long-term debt.
|
|
Amount
|
||||
|
(In millions)
|
||||
|
CompX
|
$ | 4.7 | ||
|
NL Parent and wholly-owned subsidiaries
|
10.4 | |||
|
Total
|
$ | 15.1 | ||
|
·
|
pertain to the maintenance of records that in reasonable detail accurately and fairly reflect transactions and dispositions of our assets;
|
|
·
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures are made only in accordance with authorizations of our management and directors; and
|
|
·
|
provide reasonable assurance regarding prevention or timely detection of an unauthorized acquisition, use or disposition of assets that could have a material effect on our Condensed Consolidated Financial Statements.
|
|
|
31.1 - Certification
|
|
|
31.2 - Certification
|
|
|
32.1 – Certification
|
|
Date: May 3, 2011
|
/s/ Gregory M. Swalwell
|
|
|
Gregory M. Swalwell
|
||
|
(Vice President, Finance and
Chief Financial Officer,
Principal Financial Officer)
|
||
|
Date: May 3, 2011
|
/s/ Tim C. Hafer
|
|
|
Tim C. Hafer
|
||
|
(Vice President and Controller,
Principal Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|